Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
[PubMed ID: 19085093]
[32] found that exendin-4 mitigated resistance to the androgen receptor inhibitor enzalutamide in prostate cancer via the PI3K/AKT/mTOR pathway, suggesting that a combination of exendin-4 with enzalutamide may be a more effective therapeutic option for advanced prostate cancer
Now, findings from mouse studies published in the Journal of Virology suggest the drugs could also benefit people with type 2 diabetes who develop pulmonary fibrosis months or years after contracting SARS-CoV-2, the virus that causes COVID-19
Human clinical evidence There are only two categories of human dataand neither supports its use in arthritis
This suggests binding, and uptake interactions of heme with CD36 receptors, a well-conserved protein across mammalian species, may exist
What this means for plan members That dynamic creates an unusual situation where the brand and the generic cost the same and Broussenko concedes this changes the calculus for patients
US$ 24.95
US$ 25.50
US$ 28.68
)
US$ 28.51
